The Cohort Study of Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Endoscopic Submucosal Dissection (ESD) is currently the main method of treatment of early esophageal cancer and precancerous lesions. Therefore, the investigators are looking forward to conduct a cohort study on early esophageal cancer patients undergoing endoscopic treatment collected from Zhongshan Hospital, Fudan University, comparing the WHO standard with Japanese standard of endoscopic therapy diagnosis. In addition,the investigators will collect patients' detailed informations and analyze the risk factors for metastasis and recurrence of early esophageal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2017
CompletedFirst Posted
Study publicly available on registry
December 19, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedDecember 19, 2017
December 1, 2017
11 months
November 12, 2017
December 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.
Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.
December 1st,2017-December 1st,2018
Study Arms (2)
WHO diagnostic standard
Japan diagnostic standard
Eligibility Criteria
1. Early esophageal cancer and precancerous lesions patients undergoing endoscopic resection therapy for the first time in zhongshan hospital from September 1, 2014 to September 1,2017. 2. Early esophageal cancer and precancerous lesions patients undergoing endoscopic resection therapy for the first time in zhongshan hospital after September 1,2017.
You may qualify if:
- Older than 15-year-old
- Undergoing endoscopic Submucosal Dissection (ESD) in ZhongShan Hospital
You may not qualify if:
- Preoperative patients with recurrence and Lost to follow-up of patients within 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2017
First Posted
December 19, 2017
Study Start
January 1, 2018
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
December 19, 2017
Record last verified: 2017-12